Home > Health, Fitness & Dieting > Diseases & Physical Ailments > Diabetes > Type 2

SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models by unknow

Author:unknow , Date: December 9, 2024 ,Views: 180

SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models by unknow

Author:unknow
Format: pdf
Tags: SHR-A1403, c-Met ADC, anti-tumor, patient-derived xenograft (PDX), molecular mechanisms
Publisher: Springer US
Published: 2019-06-14T11:08:18+00:00


Download

SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models by unknow.pdf


Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.